When should I clinically suspect amyloidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Clinically Suspect Amyloidosis

You should suspect amyloidosis when a patient presents with unexplained left ventricular wall thickening >12 mm combined with low QRS voltage on ECG (voltage-mass discordance), heart failure with preserved ejection fraction in men over 60, bilateral carpal tunnel syndrome without rheumatoid arthritis, or unexplained peripheral neuropathy with autonomic dysfunction. 1, 2

Cardiac Red Flags

Primary Cardiac Indicators

  • Left ventricular wall thickness ≥12-14 mm without hypertension or aortic stenosis is the single most important structural finding 1, 2
  • Voltage-mass discordance: low QRS voltage on ECG (<0.5 mV in limb leads) despite increased wall thickness on echocardiography 1, 2
  • Heart failure with preserved ejection fraction (EF ≥40%) in men older than 60 years, particularly when disproportionately symptomatic 1
  • Intolerance to ACE inhibitors, ARBs, or beta-blockers manifesting as symptomatic hypotension that resolves when these medications are discontinued 1
  • Hypertension that paradoxically resolves over time as amyloid infiltration progresses 1

Advanced Cardiac Findings

  • Low-flow aortic stenosis (mean gradient ≤40 mm Hg) with preserved ejection fraction in patients >60 years 3
  • Atrial fibrillation accompanied by right ventricular wall thickening on echocardiography 3
  • Apical-sparing pattern on longitudinal strain imaging (apical-to-basal strain ratio >2.1) 2
  • Restrictive cardiomyopathy pattern with biatrial enlargement and restrictive transmitral Doppler filling 2
  • NT-proBNP levels disproportionately elevated (>3000 pg/mL) relative to the clinical degree of heart failure 1, 2
  • Elevated troponin levels out of proportion to clinical context 1

Musculoskeletal Red Flags

  • Bilateral carpal tunnel syndrome in males without rheumatoid arthritis or occupational trauma, especially if occurring years before cardiac symptoms 1, 2
  • Lumbar spinal stenosis requiring surgical intervention 1, 2
  • Spontaneous biceps tendon rupture without significant trauma 1
  • Previous orthopedic procedures that may have been early manifestations of amyloid deposition 1

Neurologic Red Flags

  • Unexplained sensorimotor peripheral neuropathy with length-dependent axonal and demyelinating features 1, 4
  • Autonomic dysfunction: orthostatic hypotension, erectile dysfunction, sweating abnormalities, gastroparesis, or chronic diarrhea 1, 5, 4
  • Painful paresthesias with progressive neuropathy 4

Gastrointestinal Red Flags

  • Unexplained chronic diarrhea or constipation, particularly with evidence of gastrointestinal dysmotility 1, 5
  • Pseudo-obstruction carries particularly grave prognosis 5
  • Unexplained weight loss with gastrointestinal symptoms 5, 4
  • Hepatomegaly with mildly elevated alkaline phosphatase but otherwise normal liver function 1, 5

Highly Specific Signs (AL Amyloidosis)

  • Macroglossia (enlarged tongue) is highly specific but insensitive 2, 6, 5
  • Periorbital purpura ("raccoon eyes") is pathognomonic when present 2, 6
  • Acquired factor X deficiency with unexplained coagulopathy 3

Renal Red Flags

  • Unexplained proteinuria, particularly nephrotic-range proteinuria (>3.5 g/24 hours) 1, 3, 5
  • Progressive renal dysfunction without clear etiology 3

High-Risk Populations

ATTR Amyloidosis

  • African Americans >60 years with heart failure: approximately 3-4% carry the Val122Ile variant, and 10% of African Americans with heart failure over 60 are carriers 1
  • Individuals of northwest Irish descent: approximately 1% carry the Thr60Ala variant 1
  • Older men hospitalized for heart failure with unexplained left ventricular hypertrophy 1

AL Amyloidosis

  • All patients with MGUS should be routinely screened with focused history, physical examination, and urine albumin assessment 6
  • Patients with multiple myeloma (15% of AL amyloidosis patients have multiple myeloma) 5

Common Misdiagnoses to Avoid

  • Hypertrophic cardiomyopathy: amyloidosis is frequently mistaken for HCM when wall thickening is present 1
  • Generic HFpEF of unknown cause: many cases labeled as undifferentiated HFpEF are actually undiagnosed amyloidosis 1
  • Idiopathic peripheral neuropathy: unexplained neuropathy warrants amyloidosis evaluation, especially with autonomic features 1, 7

Critical Clinical Patterns

  • Multisystem involvement: the combination of cardiac symptoms with neuropathy, gastrointestinal dysfunction, or musculoskeletal findings should dramatically raise suspicion 1, 7
  • Progressive symptoms despite standard therapy: patients whose heart failure worsens despite guideline-directed medical therapy warrant evaluation 1
  • Vague, nonspecific symptoms: lethargy, fatigue, weight loss, and peripheral edema may be the only presenting features, particularly in atypical presentations 8

Immediate Next Steps When Suspicion Arises

  • Order comprehensive monoclonal protein screening immediately: serum free light chain assay with κ/λ ratio, serum immunofixation electrophoresis, and urine immunofixation electrophoresis—all three tests simultaneously 3, 2
  • Obtain transthoracic echocardiography to assess wall thickness, strain pattern, and diastolic function 1, 2
  • Measure NT-proBNP and troponin to assess cardiac involvement 1, 2
  • Delays beyond 6 weeks in diagnosis are associated with increased early mortality, making prompt evaluation essential 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amyloidosis Diagnostic Workup

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Amyloidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Gastrointestinal manifestations of amyloidosis.

The American journal of gastroenterology, 2008

Research

When to Suspect a Diagnosis of Amyloidosis.

Acta haematologica, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.